Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.75−0.18 (-0.64%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Zenas BioPharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zenas BioPharma's total debt was $223.24M at Sep 30, 2026. For fiscal 2025 it was $78.64M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.64M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $223.24M | +205.9% |
| Q2 FY2026 | Jun 30, 2026 | $222.96M | – |
| Q1 FY2026 | Mar 31, 2026 | $193.63M | – |
| Q4 FY2025 | Dec 31, 2025 | $78.64M | – |
| Q3 FY2025 | Sep 30, 2025 | $72.99M | – |
See a number that looks wrong?